|
1
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dent R, Trudeau M, Pritchard KI, Hanna WM,
Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA:
Triple-negative breast cancer: Clinical features and patterns of
recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
West M, Blanchette C, Dressman H, Huang E,
Ishida S, Spang R, Zuzan H, Olson JA Jr, Marks JR and Nevins JR:
Predicting the clinical status of human breast cancer by using gene
expression profiles. Proc Natl Acad Sci USA. 98:11462–11467. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carey LA, Perou CM, Livasy CA, Dressler
LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S,
et al: Race, breast cancer subtypes, and survival in the Carolina
Breast Cancer Study. JAMA. 295:2492–2502. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kreike B, van Kouwenhove M, Horlings H,
Weigelt B, Peterse H, Bartelink H and van de Vijver MJ: Gene
expression profiling and histopathological characterization of
triple-negative/basal-like breast carcinomas. Breast Cancer Res.
9:R652007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abd El-Rehim DM, Ball G, Pinder SE, Rakha
E, Paish C, Robertson JF, Macmillan D, Blamey RW and Ellis IO:
High-throughput protein expression analysis using tissue microarray
technology of a large well-characterised series identifies
biologically distinct classes of breast cancer confirming recent
cDNA expression analyses. Int J Cancer. 116:340–350. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Savage K, Leung S, Todd SK, Brown LA,
Jones RL, Robertson D, James M, Parry S, Rodrigues Pinilla SM,
Huntsman D, et al: Distribution and significance of caveolin 2
expression in normal breast and invasive breast cancer: An
immunofluorescence and immunohistochemical analysis. Breast Cancer
Res Treat. 110:245–256. 2008. View Article : Google Scholar
|
|
8
|
Kim JY, Ahn HJ, Ryu JH, Suk K and Park JH:
BH3-only protein Noxa is a mediator of hypoxic cell death induced
by hypoxia-inducible factor 1α. J Exp Med. 199:113–124. 2004.
View Article : Google Scholar
|
|
9
|
Oliver PL, Bitoun E, Clark J, Jones EL and
Davies KE: Mediation of Af4 protein function in the cerebellum by
Siah proteins. Proc Natl Acad Sci USA. 101:14901–14906. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Habelhah H, Laine A, Erdjument-Bromage H,
Tempst P, Gershwin ME, Bowtell DD and Ronai Z: Regulation of
2-oxoglu-tarate (alpha-ketoglutarate) dehydrogenase stability by
the RING finger ubiquitin ligase Siah. J Biol Chem.
279:53782–53788. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Carthew RW and Rubin GM: seven in
absentia, a gene required for specification of R7 cell fate in the
Drosophila eye. Cell. 63:561–577. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu G, Chung YL, Glover T, Valentine V,
Look AT and Fearon ER: Characterization of human homologs of the
Drosophila seven in absentia (sina) gene. Genomics. 46:103–111.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmidt RL, Park CH, Ahmed AU, Gundelach
JH, Reed NR, Cheng S, Knudsen BE and Tang AH: Inhibition of
RAS-mediated transformation and tumorigenesis by targeting the
downstream E3 ubiquitin ligase seven in absentia homologue. Cancer
Res. 67:11798–11810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qi J, Nakayama K, Gaitonde S, Goydos JS,
Krajewski S, Eroshkin A, Bar-Sagi D, Bowtell D and Ronai Z: The
ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by
HIF-dependent and -independent pathways. Proc Natl Acad Sci USA.
105:16713–16718. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ahmed AU, Schmidt RL, Park CH, Reed NR,
Hesse SE, Thomas CF, Molina JR, Deschamps C, Yang P, Aubry MC, et
al: Effect of disrupting seven-in-absentia homolog 2 function on
lung cancer cell growth. J Natl Cancer Inst. 100:1606–1629. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Finn RS, Dering J, Ginther C, Wilson CA,
Glaspy P, Tchekmedyian N and Slamon DJ: Dasatinib, an orally active
small molecule inhibitor of both the src and abl kinases,
selectively inhibits growth of basal-type/“triple-negative” breast
cancer cell lines growing in vitro. Breast Cancer Res Treat.
105:319–326. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kao J, Salari K, Bocanegra M, Choi YL,
Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar
AF, et al: Molecular profiling of breast cancer cell lines defines
relevant tumor models and provides a resource for cancer gene
discovery. PLoS One. 4:e61462009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Neve RM, Chin K, Fridlyand J, Yeh J,
Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, et al: A
collection of breast cancer cell lines for the study of
functionally distinct cancer subtypes. Cancer Cell. 10:515–527.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Payne RE, Yagüe E, Slade MJ,
Apostolopoulos C, Jiao LR, Ward B, Coombes RC and Stebbing J:
Measurements of EGFR expression on circulating tumor cells are
reproducible over time in metastatic breast cancer patients.
Pharmacogenomics. 10:51–57. 2009. View Article : Google Scholar
|
|
20
|
Charafe-Jauffret E, Ginestier C, Monville
F, Finetti P, Adélaïde J, Cervera N, Fekairi S, Xerri L, Jacquemier
J, Birnbaum D, et al: Gene expression profiling of breast cell
lines identifies potential new basal markers. Oncogene.
25:2273–2284. 2006. View Article : Google Scholar
|
|
21
|
Nielsen TO, Hsu FD, Jensen K, Cheang M,
Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler
L, et al: Immunohistochemical and clinical characterization of the
basal-like subtype of invasive breast carcinoma. Clin Cancer Res.
10:5367–5374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu G, Zhang S, Vidal M, Baer JL, Xu T and
Fearon ER: Mammalian homologs of seven in absentia regulate DCC via
the ubiquitin-proteasome pathway. Genes Dev. 11:2701–2714. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Boehm J, He Y, Greiner A, Staudt L and
Wirth T: Regulation of BOB.1/OBF1 stability by SIAH. EMBO J.
20:4153–4162. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tiedt R, Bartholdy BA, Matthias G, Newell
JW and Matthias P: The RING finger protein Siah-1 regulates the
level of the transcriptional coactivator OBF-1. EMBO J.
20:4143–4152. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Habelhah H, Frew IJ, Laine A, Janes PW,
Relaix F, Sassoon D, Bowtell DD and Ronai Z: Stress-induced
decrease in TRAF2 stability is mediated by Siah2. EMBO J.
21:5756–5765. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakayama K, Frew IJ, Hagensen M, Skals M,
Habelhah H, Bhoumik A, Kadoya T, Erdjument-Bromage H, Tempst P,
Frappell PB, et al: Siah2 regulates stability of
prolyl-hydroxylases, controls HIF1α abundance, and modulates
physiological responses to hypoxia. Cell. 117:941–952. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakayama K, Gazdoiu S, Abraham R, Pan ZQ
and Ronai Z: Hypoxia-induced assembly of prolyl hydroxylase PHD3
into complexes: Implications for its activity and susceptibility
for degradation by the E3 ligase Siah2. Biochem J. 401:217–226.
2007. View Article : Google Scholar :
|
|
28
|
Germani A, Romero F, Houlard M, Camonis J,
Gisselbrecht S, Fischer S and Varin-Blank N: hSiah2 is a new Vav
binding protein which inhibits Vav-mediated signaling pathways. Mol
Cell Biol. 19:3798–3807. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nadeau RJ, Toher JL, Yang X, Kovalenko D
and Friesel R: Regulation of Sprouty2 stability by mammalian
Seven-in-Absentia homolog 2. J Cell Biochem. 100:151–160. 2007.
View Article : Google Scholar
|
|
30
|
Hu Z, Fan C, Oh DS, Marron JS, He X,
Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, et al: The
molecular portraits of breast tumors are conserved across
microarray platforms. BMC Genomics. 7:962006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khurana A, Nakayama K, Williams S, Davis
RJ, Mustelin T and Ronai Z: Regulation of the ring finger E3 ligase
Siah2 by p38 MAPK. J Biol Chem. 281:35316–35326. 2006. View Article : Google Scholar : PubMed/NCBI
|
